-+ 0.00%
-+ 0.00%
-+ 0.00%

FORTRESS BIOTECH ANNOUNCES AN EXCLUSIVE LICENSE AGREEMENT FOR FB-607 FOR THE TREATMENT OF IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D)

Reuters·11/10/2026 21:05:06

Please log in to view news